'Evolving' With Health Care, CHPA Considers Device, Supplement Sectors
This article was originally published in The Pink Sheet
Executive Summary
CHPA's 2020 project is an internal analysis on how it can evolve as its members broaden into additional business categories. President and CEO Scott Melville says the effort is necessary to keep up with the “lightning speed” of health care changes.
You may also be interested in...
OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA
Imminent OTC monograph reform legislation signals an agreement between industry and FDA on details of a proposal, which also includes a potential user fee program. CHPA also is hopeful for legislation restoring direct OTC drug purchases with pre-tax savings accounts.
Hawaii's Proposed Oxybenzone Sunscreen Ban Fails Science Test – CHPA
CHPA commits to fighting against onslaught of bills in Hawaii aiming to ban or limit the use of oxybenzone-containing sunscreens, says CEO and President Scott Melville during his address on 2017 priorities during the CHPA Annual Executive Conference in Amelia Island, Fla. March 21.
Technology Gap Separates OTC Drug Firms From Self-Care Sales Growth
OTC drug firms should offer more digital tools that guide consumers in product purchases, says a health care marketing executive. The American Pharmacists Association suggests firms also strengthen outreach with pharmacists.